Connect Biopharma Holdings Limited Increase (Decrease) in Other Noncurrent Liabilities
Connect Biopharma Holdings Limited (CNTB) reported Increase (Decrease) in Other Noncurrent Liabilities of -$7.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-12
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$4.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$3.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$4.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$4.00K, a 101.62% decline year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$518.00K, a 328.19% decline from fiscal 2024.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent liabilities for fiscal 2024 was $227.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$7.00K 10-Q · filed 2026-08-12 | -$11.00K derived: sum of 3 quarters · filed 2026-08-12 | -$15.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$3.00K 10-Q · filed 2026-05-12 | -$7.00K derived: sum of 2 quarters · filed 2026-05-12 | -$11.00K derived: sum of 3 quarters · filed 2026-05-12 | -$516.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.00K derived: sum of 2 quarters · filed 2026-03-31 | -$513.00K derived: sum of 3 quarters · filed 2026-08-12 | -$518.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$509.00K derived: sum of 2 quarters · filed 2026-08-12 | -$514.00K 10-Q · filed 2025-11-12 | -$523.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$510.00K 10-Q · filed 2026-08-12 | -$519.00K derived: sum of 3 quarters · filed 2026-08-12 | -$272.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-12 | -$14.00K derived: sum of 2 quarters · filed 2026-05-12 | $233.00K derived: sum of 3 quarters · filed 2026-05-12 | $227.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $238.00K derived: sum of 2 quarters · filed 2026-03-31 | $232.00K derived: sum of 3 quarters · filed 2026-03-31 | $227.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $241.00K derived: sum of 2 quarters · filed 2025-11-12 | $236.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$11.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$5.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |